Published in Gene Therapy Weekly, October 14th, 2004
Very recent developments in gene therapy for hemophilia in the UK have resulted in a cure in the laboratory. Ted Tuddenham, director of MRC Haemostasis and Thrombosis Research Group, Imperial College and chairman of the KD Trust, said, "The KD Trust has reviewed results of key worldwide gene therapy for hemophilia research projects, noting the strengths, weaknesses and wide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.